PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.2832018503872-882NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic LeukemiaEun Sang Yi, Young Bae Choi, Rihwa Choi, Na Hee Lee, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Soo-Youn Lee, Hong Hoe Koohttp://e-crt.org/upload/pdf/crt-2017-283.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.283, http://www.e-crt.org/upload/pdf/crt-2017-283.pdf
Leukemia Research10.1016/j.leukres.2017.09.01220176217-22Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemiaMinu Singh, Prateek Bhatia, Sanjeev Khera, Amita Trehanhttps://api.elsevier.com/content/article/PII:S0145212617305209?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145212617305209?httpAccept=text/plain
Frontiers in Pharmacology10.3389/fphar.2019.00916201910ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic LeukemiaBorhan Moradveisi, Samar Muwakkit, Fatemeh Zamani, Ebrahim Ghaderi, Ebrahim Mohammadi, Nathalie K. Zgheibhttps://www.frontiersin.org/article/10.3389/fphar.2019.00916/full
Genes10.3390/genes110605942020116594Association of NUDT15 c.415C>T and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic LeukemiaSunitha Kodidela, Patchava Dorababu, Dimpal N. Thakkar, Biswajit Dubashi, Rajan Sundaram, Niveditha Muralidharan, Ravi Prasad Nidanapu, Anil Aribandi, Suresh Chandra Pradhan, Chakradhara Rao Satyanarayana Uppugundurihttps://www.mdpi.com/2073-4425/11/6/594/pdf
Russian journal of hematology and transfusiology10.35754/0234-5730-2021-66-2-253-2622021662253-262Significance of TPMT and NUDT15 variants in 6-mercaptopurine metabolism in acute lymphoblastic leukaemia/lymphoma patientsE. S. Kotova, O. A. Gavrilina, A. B. Sudarikovhttps://www.htjournal.ru/jour/article/viewFile/287/214
Bone Marrow Transplantation10.1038/sj.bmt.17045542004342189-191Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemiaA Athanasiadou, K Stamatopoulos, I Sakellari, I Zorbas, M Gaitatzi, A Fassas, A Anagnostopouloshttp://www.nature.com/articles/1704554, http://www.nature.com/articles/1704554.pdf, http://www.nature.com/articles/1704554.pdf
The Pharmacogenomics Journal10.1038/tpj.2017.122017182275-280Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemiaY Tanaka, H Nakadate, K Kondoh, K Nakamura, K Koh, A Manabehttp://www.nature.com/articles/tpj201712.pdf, http://www.nature.com/articles/tpj201712, http://www.nature.com/doifinder/10.1038/tpj.2017.12, http://www.nature.com/articles/tpj201712.pdf
Children10.3390/children8030224202183224The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic LeukemiaJae Min Lee, Ye Jee Shim, Do-Hoon Kim, Nani Jung, Jung-Sook Hahttps://www.mdpi.com/2227-9067/8/3/224/pdf
Leukemia10.1038/sj.leu.24040282005201165-167Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemiaA M Kustanovich, M V Belevtsev, I V Stasevich, T V Savitskaya, R I Jutzkevich, N N Savva, O V Aleinikovahttp://www.nature.com/articles/2404028.pdf, http://www.nature.com/articles/2404028, http://www.nature.com/articles/2404028.pdf
Leukemia10.1038/sj.leu.2401986200115174-796-Mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemiaK Schmiegelow, U Bretton-Meyerhttp://www.nature.com/articles/2401986.pdf, http://www.nature.com/articles/2401986, http://www.nature.com/articles/2401986.pdf